Abstract:MOTIVATION:The measurement of disease biomarkers in easily-obtained bodily fluids has opened the door to a new type of non-invasive medical diagnostics. New technologies are being developed and fine-tuned in order to make this possibility a reality. One such technology is Field Asymmetric Ion Mobility Spectrometry (FAIMS), which allows the measurement of volatile organic compounds (VOCs) in biological samples such as urine. These VOCs are known to contain a range of information on the relevant person's metabolism and can in principle be used for disease diagnostic purposes. Key to the effective use of such data are well-developed data processing pipelines, which are necessary to extract the most useful data from the complex underlying biological structure. RESULTS:In this study, we present a new data analysis pipeline for FAIMS data, and demonstrate a number of improvements over previously used methods. We evaluate the effect of a series of candidate operational steps during data processing, such as the use of wavelet transforms, principal component analysis (PCA), and classifier ensembles. We also demonstrate the use of FAIMS data in our pipeline to diagnose diabetes on the basis of a simple urine sample using machine learning classifiers. We present results for data generated from a case-control study of 115 urine samples, collected from 72 type II diabetic patients, with 43 healthy volunteers as negative controls. The resulting pipeline combines the steps that resulted in the best classification model performance. These include the use of a two-dimensional discrete wavelet transform, and the Wilcoxon rank-sum test for feature selection. We are able to achieve a best ROC curve AUC of 0.825 (0.747-0.9, 95% CI) for classification of diabetes vs control. We also note that this result is robust to changes in the data pipeline and different analysis runs, with AUC > 0.80 achieved in a range of cases. This is a substantial improvement in performance over previously used data processing methods in this area. Our ability to make strong statements about FAIMS ability to diagnose diabetes is sadly limited, as we found confounding effects from the demographics when including these data in the pipeline. The demographics alone produced a best AUC of 0.87 (0.795-0.94, 95% CI). While the combination of the demographics and FAIMS data resulted in an improvement on the AUC (0.907; 0.848-0.97, 95% CI), it did not prove to be a significant difference. Nevertheless, the pipeline itself shows a significant improvement in performance over more basic methods which have been used with FAIMS data in the past.

Variation In Gas And Volatile Compound Emissions From Human Urine As It Ages, Measured By An Electronic Nose

Pre-analytical and Analytical Variables That Influence Urinary Volatile Organic Compound Measurements

Non-Invasive Diagnosis of Diabetes by Volatile Organic Compounds in Urine Using FAIMS and Fox4000 Electronic Nose

A Portable Electronic Nose Intended for Home Healthcare Based on a Mixed Sensor Array and Multiple Desorption Methods

Investigating the effects of storage conditions on urinary volatilomes for their reliability in disease diagnosis

T1267 the Gut in Health and Disease: Scenting the Difference by ‘electronic Nose’

Short- and Long-Term Stability of Aromatic Amines in Human Urine

Review Article: Next Generation Diagnostic Modalities in Gastroenterology – Gas Phase Volatile Compound Biomarker Detection

Freeze-drying: an alternative method for the analysis of volatile organic compounds in the headspace of urine samples using solid phase micro-extraction coupled to gas chromatography - mass spectrometry

Quantitation of ethanol in UTI assay for volatile organic compound detection by electronic nose using the validated headspace GC-MS method

PP-006 the Gut in Health and Disease: Scenting the Difference by “electronic Nose”

A comparative study of the analysis of human urine headspace using gas chromatography-mass spectrometry

Mapping of Urinary Volatile Organic Compounds by a Rapid Analytical Method Using Gas Chromatography Coupled to Ion Mobility Spectrometry (GC–IMS)

Urine organic acid metabolomic profiling by gas chromatography mass spectrometry: Assessment of solvent extract evaporation parameters on the recovery of key diagnostic metabolites

A stability study of carbonyl compounds in Tedlar bags by a fabricated MEMS microreactor approach

Human Exhaled Breath Analysis Trends in Techniques and Its Potential Applications in Non-Invasive Clinical Diagnosis

Identifying Volatile Metabolite Signatures for the Diagnosis of Bacterial Respiratory Tract Infection Using Electronic Nose Technology: A Pilot Study.

Human Urinary Volatilome Analysis in Renal Cancer by Electronic Nose

A Novel Breath Analysis System Based on Electronic Olfaction

The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva

An Improved Machine Learning Pipeline for Urinary Volatiles Disease Detection: Diagnosing Diabetes.